News & Events

Select year 2026 2025 2024 2023 2022 2021 2020 2019 all
2026-02-18
ANSM Authorizes First-in-Human Phase I Trial of ODI-2001, Odimma Therapeutics’ Personalized Cancer Immunotherapy
Read more